Rapid Response From Angiogenesis 2024: State of the Science in Management of nAMD, DME, and RVO

Rapid Response From Angiogenesis 2024: State of the Science in Management of nAMD, DME, and RVO

In this CE activity, experts in the field review the latest clinical findings and real-world evidence regarding the use of currently available medical advances for the treatment of patients with nAMD, DME, and RVO, and evaluate the latest clinical data on emerging treatment options for the medical management of these patients.

  • Provider:Vindico Medical Education, LLC
  • Activity Link: https://cme.healio.com/ophthalmology/20240223/rapid-response-from-angiogenesis-2024/overview
  • Start Date: 2024-02-23 06:00:00
  • End Date: 2024-02-23 06:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
  • Commercial Support: Source: Genentech, a member of the Roche Group - Amount: 64468.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.